Unilateral Tamoxifen-Induced Retinopathy as a Consequence of Breast Cancer Treatment—Multimodal Imaging Value

Tamoxifen is a drug used in breast cancer therapy, which inhibits the division of neoplastic cells targeting estrogen receptors. The drug is generally well-tolerated and its use does not cause serious side-effects. The standard dose of the drug is 20 mg once a day for 3 to 5 years. Available epidemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabelska, Paulina, Paczwa, Katarzyna, Ciszewska, Joanna, Różycki, Radosław, Gołębiewska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Interesting Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093114/
https://www.ncbi.nlm.nih.gov/pubmed/37046468
http://dx.doi.org/10.3390/diagnostics13071250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093114/
https://www.ncbi.nlm.nih.gov/pubmed/37046468
http://dx.doi.org/10.3390/diagnostics13071250

Ejemplares similares